Treatment of Idiopathic Congenital Hydrocephalus in Infants
For an infant with idiopathic hydrocephalus present since birth, both ventriculoperitoneal (VP) shunt placement and endoscopic third ventriculostomy (ETV) are acceptable treatment options with equivalent outcomes, though if a shunt is placed, antibiotic-impregnated shunt tubing should be used to reduce infection risk. 1, 2
Surgical Treatment Options
The Congress of Neurological Surgeons guidelines (updated 2020) confirm that both VP shunts and ETV demonstrate equivalent outcomes in pediatric hydrocephalus across the clinical etiologies studied 1, 2. This represents Level II evidence with moderate clinical certainty. The choice between these two approaches depends on several factors:
VP Shunt Considerations
- Antibiotic-impregnated shunt tubing is strongly recommended (Level I evidence) as it significantly reduces postoperative shunt infection rates compared to conventional silicone hardware, particularly in children 1
- This represents the highest quality evidence from a multicenter randomized controlled trial
- Traditional concerns include lifelong shunt dependency and risk of malfunction requiring revision
ETV Considerations
- ETV offers the potential advantage of avoiding permanent shunt hardware and its associated long-term complications
- However, ETV alone has limited success in young infants - in one study, ETV alone achieved only 20% success at 4 years in infants with congenital idiopathic hydrocephalus 3
- ETV combined with choroid plexus cauterization (ETV/CPC) shows significantly better outcomes - 72.4% success at 4 years in the same population (hazard ratio 6.9) 3
- The younger the infant, the less successful ETV tends to be due to greater brain compliance
Important Clinical Nuances
Age is a critical factor in surgical decision-making. Infants under 6 months have particularly high failure rates with both approaches:
Given these high failure rates, temporizing procedures may be considered first in very young infants (such as ventriculosubgaleal shunts or ventricular access devices), allowing 1-2 months of development before attempting definitive treatment 4. This strategy acknowledges that "definitive" treatment in infants under 6 months may effectively function as unpredictable temporized treatment anyway.
Follow-Up Requirements
Regardless of surgical approach chosen, these infants require:
- Serial head circumference measurements to monitor for rapid increases across percentiles
- Clinical monitoring for signs of shunt malfunction or ETV failure: bulging fontanelle, lethargy, vomiting, upgaze palsy, bradycardia
- Neuroimaging surveillance (head ultrasound in infants with open fontanelles, MRI for more detailed assessment)
- Long-term neurodevelopmental follow-up, as outcomes vary widely based on timing of intervention and underlying pathophysiology 5
Common Pitfalls to Avoid
- Do not assume one procedure is universally superior - the evidence shows equivalence, so individualize based on anatomy, age, and surgeon expertise
- Do not use standard silicone shunt tubing - antibiotic-impregnated catheters are now standard of care 1
- Do not perform ETV alone in young infants with congenital hydrocephalus - add choroid plexus cauterization if choosing this approach 3
- Do not delay intervention once hydrocephalus is symptomatic, as this impacts neurodevelopmental outcomes 6, 5